Pyrrolopyridine-aniline compounds for treatment of dermal disorders
US12428418B2 · kind B2 · utility
0Cited by
2References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 17, 2024 |
| Grant date | Sep 30, 2025 |
| Priority date | — |
| Expiry date | Jun 17, 2044 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are compounds, pharmaceutical compositions comprising the compounds, methods of preparing the compounds, and methods of using the compounds and compositions in treating diseases or disorders in a subject where the subject is in need of an inhibitor of MEK where the compound is according to Formula (I):
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.